Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Sandoz Group Stock News

SDZXFOTCQX

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$39.37

At close: Apr 21, 10:39 AM EDT

$31.66

-7.71-19.59%

After Hours: Feb 21, 9:08 AM EDT

Sandoz Group (SDZXF) Forecast

News

Earnings Sandoz Group (SDZXF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Sandoz Group Stock News | OTC:SDZXF | Benzinga

Get the latest news on Sandoz Group stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Sandoz Group performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, April 14, 2025

Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug
Vandana Singh - Apr 14, 2025, 12:32PM

Monday, February 24, 2025

NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects
Vandana Singh - Feb 24, 2025, 12:39PM
Sandoz Launches FDA-Approved Pyzchiva Biosimi...
Benzinga Newsdesk - Feb 24, 2025, 1:22AM

Tuesday, December 03, 2024

Why Is Coherus BioSciences Stock Trading Higher On Tuesday?
Vandana Singh - Dec 3, 2024, 9:34AM

Friday, November 15, 2024

Sandoz Gains European Commission Approval For...
Benzinga Newsdesk - Nov 15, 2024, 1:32AM

Wednesday, September 11, 2024

UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
Vandana Singh - Sep 11, 2024, 2:59PM

Tuesday, April 30, 2024

Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
Vandana Singh - Apr 30, 2024, 11:54AM

Thursday, February 29, 2024

Generic/Biosimilar Player Sandoz Settles US Price Fixing Case For $265M
Vandana Singh - Feb 29, 2024, 11:19AM

Monday, January 22, 2024

Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today?
Vandana Singh - Jan 22, 2024, 9:41AM

Monday, December 04, 2023

Venue Turmoil: Pharma Companies Oppose States' Bid to Relocate Price-Fixing Cases
Vandana Singh - Dec 4, 2023, 2:02PM

Tuesday, November 28, 2023

Novartis Outlines Pure-Play Strategy Progress After Generics Business Spin-Off
Vandana Singh - Nov 28, 2023, 10:55AM

Wednesday, October 04, 2023

Novartis Shares Decline As Spin Off Sandoz's Market Debut Falls Short of Expected Valuation
Vandana Singh - Oct 4, 2023, 12:35PM

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved